S&P 500   4,269.80 (-0.10%)
DOW   33,859.97 (-0.35%)
QQQ   328.75 (+0.08%)
AAPL   173.78 (-0.44%)
MSFT   290.45 (-0.30%)
META   174.40 (-0.26%)
GOOGL   119.90 (+0.29%)
AMZN   142.04 (-0.04%)
TSLA   910.31 (-0.18%)
NVDA   186.65 (+1.80%)
NIO   19.82 (-1.29%)
BABA   90.38 (+0.68%)
AMD   100.27 (+2.04%)
MU   62.62 (+1.62%)
T   18.40 (-0.11%)
CGC   3.78 (-6.90%)
F   15.98 (-0.31%)
GE   79.03 (-1.11%)
DIS   122.16 (-0.53%)
AMC   20.12 (-5.81%)
PYPL   98.48 (-0.95%)
PFE   48.53 (-1.50%)
NFLX   244.88 (+1.55%)
S&P 500   4,269.80 (-0.10%)
DOW   33,859.97 (-0.35%)
QQQ   328.75 (+0.08%)
AAPL   173.78 (-0.44%)
MSFT   290.45 (-0.30%)
META   174.40 (-0.26%)
GOOGL   119.90 (+0.29%)
AMZN   142.04 (-0.04%)
TSLA   910.31 (-0.18%)
NVDA   186.65 (+1.80%)
NIO   19.82 (-1.29%)
BABA   90.38 (+0.68%)
AMD   100.27 (+2.04%)
MU   62.62 (+1.62%)
T   18.40 (-0.11%)
CGC   3.78 (-6.90%)
F   15.98 (-0.31%)
GE   79.03 (-1.11%)
DIS   122.16 (-0.53%)
AMC   20.12 (-5.81%)
PYPL   98.48 (-0.95%)
PFE   48.53 (-1.50%)
NFLX   244.88 (+1.55%)
S&P 500   4,269.80 (-0.10%)
DOW   33,859.97 (-0.35%)
QQQ   328.75 (+0.08%)
AAPL   173.78 (-0.44%)
MSFT   290.45 (-0.30%)
META   174.40 (-0.26%)
GOOGL   119.90 (+0.29%)
AMZN   142.04 (-0.04%)
TSLA   910.31 (-0.18%)
NVDA   186.65 (+1.80%)
NIO   19.82 (-1.29%)
BABA   90.38 (+0.68%)
AMD   100.27 (+2.04%)
MU   62.62 (+1.62%)
T   18.40 (-0.11%)
CGC   3.78 (-6.90%)
F   15.98 (-0.31%)
GE   79.03 (-1.11%)
DIS   122.16 (-0.53%)
AMC   20.12 (-5.81%)
PYPL   98.48 (-0.95%)
PFE   48.53 (-1.50%)
NFLX   244.88 (+1.55%)
S&P 500   4,269.80 (-0.10%)
DOW   33,859.97 (-0.35%)
QQQ   328.75 (+0.08%)
AAPL   173.78 (-0.44%)
MSFT   290.45 (-0.30%)
META   174.40 (-0.26%)
GOOGL   119.90 (+0.29%)
AMZN   142.04 (-0.04%)
TSLA   910.31 (-0.18%)
NVDA   186.65 (+1.80%)
NIO   19.82 (-1.29%)
BABA   90.38 (+0.68%)
AMD   100.27 (+2.04%)
MU   62.62 (+1.62%)
T   18.40 (-0.11%)
CGC   3.78 (-6.90%)
F   15.98 (-0.31%)
GE   79.03 (-1.11%)
DIS   122.16 (-0.53%)
AMC   20.12 (-5.81%)
PYPL   98.48 (-0.95%)
PFE   48.53 (-1.50%)
NFLX   244.88 (+1.55%)
NASDAQ:CYAN

Cyanotech - CYAN Stock Forecast, Price & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$2.65
$2.70
50-Day Range
$2.83
$3.26
52-Week Range
$2.37
$6.29
Volume
13,984 shs
Average Volume
23,357 shs
Market Capitalization
$16.77 million
P/E Ratio
15.88
Dividend Yield
N/A
Price Target
N/A
CYAN stock logo

About Cyanotech (NASDAQ:CYAN) Stock

Cyanotech Corp. engages in the cultivation, production, and sale of natural products derived from microalgae for the health and human nutrition markets worldwide. Its products include BioAstin Hawaiian Astaxanthin, a dietary antioxidant, which is used as a human dietary supplement and dietary ingredient to support and maintain the body's natural inflammatory response, enhance skin, and support eye, joint, and immune health; and Hawaiian Spirulina Pacifica, a nutrient-rich dietary supplement that is used for extra energy, a strengthened immune system, cardiovascular benefits, and as a source of antioxidant carotenoids. The company was founded by Gerald R. Cysewski in 1983 and is headquartered in Kailua-Kona, HI.

Receive CYAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyanotech and its competitors with MarketBeat's FREE daily newsletter.

CYAN Stock News Headlines

Cyanotech Corporation (CYAN)
The Global Market for Carotenoids
See More Headlines

Receive CYAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyanotech and its competitors with MarketBeat's FREE daily newsletter.

CYAN Company Calendar

Last Earnings
6/22/2022
Today
8/18/2022
Next Earnings (Estimated)
11/09/2022
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Medicinals & botanicals
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:CYAN
Employees
95
Year Founded
N/A

Profitability

Net Income
$2.15 million
Pretax Margin
3.53%

Debt

Sales & Book Value

Annual Sales
$35.97 million
Cash Flow
$0.67 per share
Book Value
$3.07 per share

Miscellaneous

Free Float
4,624,000
Market Cap
$16.77 million
Optionable
Not Optionable
Beta
0.43














CYAN Stock - Frequently Asked Questions

When is Cyanotech's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 9th 2022.
View our CYAN earnings forecast
.

How were Cyanotech's earnings last quarter?

Cyanotech Co. (NASDAQ:CYAN) issued its quarterly earnings data on Wednesday, June, 22nd. The biotechnology company reported $0.04 earnings per share for the quarter. The biotechnology company earned $8.13 million during the quarter. Cyanotech had a net margin of 3.44% and a trailing twelve-month return on equity of 6.08%.

What is Brent D. Bailey's approval rating as Cyanotech's CEO?

4 employees have rated Cyanotech Chief Executive Officer Brent D. Bailey on Glassdoor.com. Brent D. Bailey has an approval rating of 68% among the company's employees.

What other stocks do shareholders of Cyanotech own?
What is Cyanotech's stock symbol?

Cyanotech trades on the NASDAQ under the ticker symbol "CYAN."

Who are Cyanotech's major shareholders?

Cyanotech's stock is owned by a variety of retail and institutional investors. Top institutional investors include Renaissance Technologies LLC (3.76%). Insiders that own company stock include Glenn Jensen, Jennifer M Johansen and Michael A / Davis.
View institutional ownership trends
.

What is Cyanotech's stock price today?

One share of CYAN stock can currently be purchased for approximately $2.70.

How much money does Cyanotech make?

Cyanotech (NASDAQ:CYAN) has a market capitalization of $16.77 million and generates $35.97 million in revenue each year. The biotechnology company earns $2.15 million in net income (profit) each year or $0.17 on an earnings per share basis.

How can I contact Cyanotech?

Cyanotech's mailing address is 73-4460 QUEEN KAAHUMANU HWY SUITE 102, KAILUA KONA HI, 96740. The official website for the company is www.cyanotech.com. The biotechnology company can be reached via phone at (808) 326-1353, via email at brussell@cyanotech.com, or via fax at 808-329-4533.

This page (NASDAQ:CYAN) was last updated on 8/18/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.